Resumen de acción AMTI
Applied Molecular Transport Inc., a clinical-stage biopharmaceutical company, engages in the design and development of a pipeline of oral biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Recompensas
Análisis de riesgos
+ 3 riesgos adicionales
Competidores de Applied Molecular Transport Inc.
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.26 |
| 52 Week High | US$0.84 |
| 52 Week Low | US$0.13 |
| Beta | 2.29 |
| 1 Month Change | 46.68% |
| 3 Month Change | 67.52% |
| 1 Year Change | -26.21% |
| 3 Year Change | -99.15% |
| 5 Year Change | n/a |
| Change since IPO | -98.54% |
Noticias y actualizaciones recientes
Recent updates
Here's Why We're A Bit Worried About Applied Molecular Transport's (NASDAQ:AMTI) Cash Burn Situation
Mar 07
We're A Little Worried About Applied Molecular Transport's (NASDAQ:AMTI) Cash Burn Rate
Nov 13Applied Molecular Transport GAAP EPS of -$0.93
Aug 04Companies Like Applied Molecular Transport (NASDAQ:AMTI) Could Be Quite Risky
Jul 27Applied Molecular Transport up 4% after hours on ulcerative colitis candidate data
Jul 05Applied Molecular: Interesting Drug Delivery Approach For The GI Tract
May 03We're Keeping An Eye On Applied Molecular Transport's (NASDAQ:AMTI) Cash Burn Rate
Apr 28We're Hopeful That Applied Molecular Transport (NASDAQ:AMTI) Will Use Its Cash Wisely
Jan 08We're Hopeful That Applied Molecular Transport (NASDAQ:AMTI) Will Use Its Cash Wisely
Aug 29Applied Molecular Transport (NASDAQ:AMTI) Is In A Good Position To Deliver On Growth Plans
Apr 05Have Insiders Been Buying Applied Molecular Transport Inc. (NASDAQ:AMTI) Shares This Year?
Feb 11Here's Why We're Not Too Worried About Applied Molecular Transport's (NASDAQ:AMTI) Cash Burn Situation
Dec 21Applied Molecular Transport reports Q3 results
Nov 12Rentabilidad de los accionistas
| AMTI | US Biotechs | Mercado US | |
|---|---|---|---|
| 7D | -11.0% | 1.5% | 1.2% |
| 1Y | -26.2% | 1.1% | 24.7% |
Rentabilidad vs. Industria: AMTI obtuvo unos resultados inferiores a los del sector US Biotechs , que el año pasado arrojó un rendimiento del -3.7%.
Rentabilidad vs. Mercado: AMTI obtuvo unos resultados inferiores a los del mercado US, que fue del 19.3% el año pasado.
Volatilidad de los precios
| AMTI volatility | |
|---|---|
| AMTI Average Weekly Movement | 13.5% |
| Biotechs Industry Average Movement | 11.7% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.0% |
Precio estable de las acciones: El precio de las acciones de AMTI ha sido volátil en los últimos 3 meses.
Volatilidad a lo largo del tiempo: La volatilidad semanal de AMTI(13%) se ha mantenido estable durante el último año, pero sigue siendo superior al 75% de las acciones de US.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 2010 | 13 | Shawn Cross | www.appliedmt.com |
Resumen de fundamentos de Applied Molecular Transport Inc.
| Estadísticas fundamentales de AMTI | |
|---|---|
| Capitalización bursátil | US$10.87m |
| Beneficios(TTM) | -US$74.79m |
| Ingresos (TTM) | n/a |
0.0x
Ratio precio-ventas (PS)-0.1x
Ratio precio-beneficio (PE)¿Está AMTI sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de AMTI | |
|---|---|
| Ingresos | US$0 |
| Coste de los ingresos | US$42.08m |
| Beneficio bruto | -US$42.07m |
| Otros gastos | US$32.71m |
| Beneficios | -US$74.79m |
Últimos beneficios comunicados
Sep 30, 2023
Próxima fecha de beneficios
n/a
| Beneficios por acción (BPA) | -1.81 |
| Margen bruto | 0.00% |
| Margen de beneficio neto | 0.00% |
| Ratio deuda/patrimonio | 0% |
¿Cómo se ha desempeñado AMTI a largo plazo?
Ver rendimiento histórico y comparativa